Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the ...

Truvada is used to treat HIV infection in adults and children, and to prevent HIV in people at high risk through pre-exposure prophylaxis (PrEP). Common side effects include nausea, fatigue, diarrhea, ...

Debates raged at the 19th International AIDS Conference was held Washington, DC from July 22 to 27, on the latest news in HIV prevention and treatment research. The conference was the first held in ...

Lenacapavir was found to be superior to background HIV incidence and Truvada for HIV prevention. Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil ...

WASHINGTON, May 10 (Reuters) - A U.S. Food and Drug Administration panel of outside experts recommended Gilead Sciences Inc's Truvada as a treatment for preventing HIV infection among people at risk ...

(Global Health): Gilead Sciences, maker of Truvada, the only drug approved to prevent infection with HIV, will donate enough of the drug to supply 200,000 patients annually for up to 11 years, federal ...

A Food and Drug Administration (FDA) panel is debating whether to make history by recommending approval of the first drug to prevent HIV infection. The advisory committee is expected to vote on ...

(Reuters) - GlaxoSmithKline said an injection every other month of its cabotegravir drug was shown to avert an HIV infection more effectively than Gilead's daily Truvada pill, potentially giving its ...

Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a ...